4
Changes in Ownership
PharmaCyte Biotech, Inc. Filed Acc 0001683168-23-008433
Options or other derivatives
- Director acquired 61,248 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WALKER WAYNE REMELL Director | 2023-11-20 | Grant or award · Stock Option (Right to Buy) | +61,248 | 61,248 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…